SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 193 filers reported holding SAGE THERAPEUTICS INC in Q2 2024. The put-call ratio across all filers is 0.24 and the average weighting 0.0%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Nationale-Nederlanden Powszechne Towarzystwo Emerytalne S.A. | 190,000 | $13,716,100 | 11.97% |
| GREAT POINT PARTNERS LLC | 796,057 | $57,467,000 | 5.00% |
| Logos Global Management LP | 190,150 | $13,727,000 | 3.38% |
| Integral Health Asset Management, LLC | 120,000 | $8,663,000 | 3.37% |
| DAFNA Capital Management LLC | 124,806 | $9,010,000 | 3.09% |
| Palo Alto Investors LP | 653,594 | $47,183,000 | 2.60% |
| Ghost Tree Capital, LLC | 150,000 | $10,829,000 | 2.06% |
| Eventide Asset Management | 790,000 | $57,030,000 | 1.61% |
| Ikarian Capital, LLC | 133,000 | $9,601,000 | 1.56% |
| Casdin Capital, LLC | 230,000 | $16,604,000 | 1.53% |